# Implementation of Precision Medicine in High-risk Prostate Cancer

> **NCT06687421** · — · RECRUITING · sponsor: **Andreas Josefsson** · enrollment: 5500 (estimated)

## Conditions studied

- Prostate Cancer

## Interventions

- **OTHER:** High-risk treatment SOC
- **OTHER:** Active monitoring
- **PROCEDURE:** Radical prostatectomy
- **RADIATION:** Radiotherapy
- **DRUG:** Androgen deprivation therapy

## Key facts

- **NCT ID:** NCT06687421
- **Lead sponsor:** Andreas Josefsson
- **Sponsor class:** OTHER_GOV
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** RECRUITING
- **Start date:** 2024-06-10
- **Primary completion:** 2054-12
- **Final completion:** 2054-12
- **Target enrollment:** 5500 (ESTIMATED)
- **Last updated:** 2025-09-03

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT06687421

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT06687421, "Implementation of Precision Medicine in High-risk Prostate Cancer". Retrieved via AI Analytics 2026-06-09 from https://api.ai-analytics.org/clinical/NCT06687421. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*